Pancreaze (pancrelipase), an approved therapy used to manage pancreatic complications in cystic fibrosis (CF), has been added as a…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Changes in dietary fat intake did not affect mucus content or lung function in a study involving a rat model…
Women who carry a mutation that can cause cystic fibrosis (CF) may be more likely to develop gestational diabetes,…
In young children with cystic fibrosis (CF), treatment with Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) may reverse a form of pancreatic damage…
The genetic defect that causes cystic fibrosis (CF) may also directly contribute to the development of pancreatic cancer, a…
The next-generation triple-combination CFTR modulator Alyftrek can be safely given to children with cystic fibrosis (CF) as young…
Sionna Therapeutics is planning a proof-of-concept Phase 2a clinical trial to test a combination of two experimental treatments for…
Splisense has begun testing its inhaled therapy SPL84 alongside standard treatment in adults with cystic fibrosis (CF)…
Writer, director, and actor Leah McKendrick has been selected as the winner of the 2026 Clairity Spotlight Award in recognition…
Cutting-edge DNA sequencing technologies for microbial surveillance have the potential to revolutionize how lung infections in people with cystic…